Provided By GlobeNewswire
Last update: Aug 4, 2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year
IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million
Read more at globenewswire.com5.97
+0.13 (+2.23%)
Find more stocks in the Stock Screener